![Patrick Simms](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Simms
Keine laufenden Positionen mehr
Profil
Patrick Simms worked as a Director of Clinical Operations at Angion Biomedica Corp.
Ehemalige bekannte Positionen von Patrick Simms
Unternehmen | Position | Ende |
---|---|---|
ANGN BIOM | Geschäftsführer | 01.01.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Angion Biomedica Corp.
![]() Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |